Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 2, 1997, Pages 365-372

  Hatlebakk, J G ^a   Berstad, A ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; ENDOSCOPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS;

EID: 0030942154     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.144320000.x     Document Type: Article

References (21)

1. Sachs G, Shin JM, Besancon M, Prinz C. The continuing development of gastric acid pump inhibitors. Aliment Pharmacol Ther 1993; 7(Suppl.1): 4-12.
2. Berstad A, Hatlebakk JG. Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies. Aliment Pharmacol Ther 1993; 7: 34-6.
3. Dorsch E, Jones J, Padgett C, Jennings D, Greski P. Lansoprazole heals moderate to severe reflux oesophagitis. Am J Gastroenterol 1990; 86: A1294(Abstract).
4. Robinson M, Kogut D, Jennings D, Levy C, Greski-Rose P, and the Lansoprazole Study Group. Lansoprazole heals erosive reflux esophagitis better than ranitidine. Gastroenterology 1992; 102: A153(Abstract).
5. Hatlebakk JG, Berstad A, Carling L, et al. Lansoprazole vs. omeprazole in short-term treatment of reflux oesophagitis. Scand J Gastroenterol 1993; 28: 224-8.
6. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903-12.
7. de Boer WA, Tytgat GNJ. Review article: drug therapy for reflux oesophagitis. Aliment Pharmacol Ther 1994; 8: 147-57.
8. Tytgat GNJ, Bianchi Porro G, Feussner H, et al. Long-term strategy for the treatment of gastro-oesophageal reflux disease. Gastroenterol Int 1991; 4: 21-32.
9. Fennerty MB, Lieberman D. H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: 'For whom the bell tolls'. Gastroenterology 1994; 107: 1545-8.
10. Tytgat GNJ, Anker Hansen OJ, Carling L, et al. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. Scand J Gastroenterol 1992; 27: 175-83.
11. Dent J, Yeomans ND, Mackinnon M, et al. Omeprazole vs. ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994; 35: 590-8.
12. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994; 121: 161-7.
13. Bate CM, Booth SN, Crowe JP, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995; 36: 492-8.
14. Koch GG, McCanless I, Ward JF. Interpretation of statistical methodology associated with maintenance trials. Am J Med 1984, 77(Suppl. 5B): 43-50.
15. Berstad A, Weberg R, Frøyshov Larsen I, Hoel B, Hauer-Jensen M. Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy. Scand J Gastroenterol 1986; 21: 55-8.
16. Ollyo J-B, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux oesophagitis. Gullet 1993, 3(Suppl. 1): 3-10.
17. Klinkenberg-Knol EC, Meuwissen SGM. Combined gastric and oesophageal 24-hour pH-monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990; 4: 485-95.
18. Robinson M, Lanza F, and the Lansoprazole Study Group. Lansoprazole for one year prevents recurrence of erosive reflux esophagitis. Gastroenterology 1994; 106: A166(Abstract).
19. Gough AL, Long RG, Cooper BT, et al. Lansoprazole vs. ranitidine in the maintenance treatment of reflux oesophagitis. Aliment Pharmacol Ther 1996; 10: 529-39.
20. Poynard T, Staub JL, Lemerez M, et al. Efficacy and safety of lansoprazole 15 mg OAD as one year maintenance treatment for erosive reflux esophagitis. Gastroenterology 1995; 108: A195(Abstract).
21. Castell DO, Richter JE, Robinson M, Sontag S. Large trial compares lansoprazole to omeprazole. Gastroenterology 1995; 108: A67(Abstract).